Total submissions: 12
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704072 | SCV000209508 | likely benign | not provided | 2020-11-04 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25637381, 21859464, 24055113, 18199528, 26991699) |
Invitae | RCV003534394 | SCV000218792 | benign | Familial adenomatous polyposis 1 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Counsyl | RCV000168133 | SCV000488505 | uncertain significance | Familial adenomatous polyposis 1 | 2016-04-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000567920 | SCV000667228 | likely benign | Hereditary cancer-predisposing syndrome | 2018-09-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Mendelics | RCV000168133 | SCV000838095 | uncertain significance | Familial adenomatous polyposis 1 | 2018-07-02 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000567920 | SCV000902832 | likely benign | Hereditary cancer-predisposing syndrome | 2016-05-22 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000159544 | SCV000918467 | benign | not specified | 2021-12-13 | criteria provided, single submitter | clinical testing | Variant summary: APC c.2847G>T (p.Met949Ile) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4.8e-05 in 250790 control chromosomes, predominantly at a frequency of 0.00068 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is approximately 9.5 fold of the estimated maximal expected allele frequency for a pathogenic variant in APC causing Familial Adenomatous Polyposis phenotype (7.1e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. c.2847G>T has been reported in the literature in at-least two individuals, one stated as affected with non-familial adenomatous polyposis and non MUTYH-associated polyposis (Azzopard_2008) and another with Ependymoma in a sequencing study of 1120 young cancer patients (Zhang_2015). These report(s) do not provide unequivocal conclusions about association of the variant with Familial Adenomatous Polyposis. At-least one co-occurrence with another pathogenic variant has been observed at our laboratory (BRCA2 c.8548_8551delGAAG, p.Glu2850fs), providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Six clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments (benign, n=1; likely benign, n=3; VUS, n=2). Based on the evidence outlined above, the variant was classified as benign. |
Sema4, |
RCV000567920 | SCV002529956 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-12-16 | criteria provided, single submitter | curation | |
Myriad Genetics, |
RCV000168133 | SCV004018521 | likely benign | Familial adenomatous polyposis 1 | 2023-02-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign. This variant has been observed at a population frequency that is significantly greater than expected given the associated disease prevalence and penetrance. |
Center for Genomic Medicine, |
RCV000159544 | SCV004025047 | likely benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003917461 | SCV004731186 | likely benign | APC-related condition | 2024-02-04 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
CSER _CC_NCGL, |
RCV000148363 | SCV000190055 | uncertain significance | Colorectal adenoma | 2014-06-01 | no assertion criteria provided | research |